/stocks — the workspaceLOADING

NVNO · All filings · Read this filing

What changed 10-Q

Item 5. Other Information

2025-10-30 compared with 2025-07-31 · 15 added, 36 removed, 12 unchanged (81% of the section changed)

Other Information

is made to our Current Report on Form 8-K filed on May 20, 2025 reporting the appointment of Jennifer Bright as Chief Financial Officer

of the Company.

Attached hereto as Exhibit 10.1 and Exhibit 99.1 are the employment agreement, dated May 19, 2025, between the Company

Bright and the Officer Indemnity Agreement entered into by and between the Company and Ms.

June 12, 2025 , Dr.

Francis Duhay , a director of the Company, adopted a “Rule 10b5-1 trading arrangement” (as defined in Item

408 of Regulation S-K of the Exchange Act) (with the first trade under the new plan not to be made prior to September 15, 2025).

trading plan will be effective until September 30, 2026 and provides for the sale of 20,000 shares of common stock.

following is a complete list of exhibits filed as part of this Form 10-Q.

1 unchanged sentence

of Item 601 of Regulation S-K.

Employment Agreement, dated as of May 19, 2025, by and between enVVeno Medical Corporation and Jennifer Bright*

Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act*

1 unchanged sentence

Certification of Chief Executive Officer and Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act**

Officer Indemnity Agreement, dated July 26, 2025, by and between enVVeno Medical Corporation and Jennifer Bright*

Inline XBRL Instance Document*

Inline XBRL Taxonomy Extension

Schema Document*

Inline XBRL Taxonomy Extension

Calculation Linkbase Document*

Inline XBRL Taxonomy Extension

Definition Linkbase Document*

Inline XBRL Taxonomy Extension

Label Linkbase Document*

Inline XBRL Taxonomy Extension

Presentation Linkbase Document*

Cover Page Interactive

Data File (embedded within the Inline XBRL document)

Filed herewith.

These certifications are furnished to the SEC pursuant

to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act

of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as

shall be expressly set forth by specific reference in such filing.

XBRL Instance Document*

XBRL Taxonomy Extension Schema Document*

XBRL Taxonomy Extension Calculation Linkbase Document*

XBRL Taxonomy Extension Definition Linkbase Document*

XBRL Taxonomy Extension Label Linkbase Document*

XBRL Taxonomy Extension Presentation Linkbase Document*

Page Interactive Data File (embedded within the Inline XBRL document)

certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes

of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing

under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on

its behalf by the undersigned, thereunto duly authorized.

July 31, 2025

October 30, 2025

MEDICAL CORPORATION

Robert Berman

Robert Berman

Chief Executive Officer

(Principal Executive Officer)

Jennifer Bright

Executive Officer

Executive Officer)

Jennifer Bright

Chief Financial Officer

(Principal Financial and

Accounting Officer)

Financial Officer

Financial and Accounting Officer)

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.